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Abstract
Background: Pregnancy-associated malaria (PAM) causing maternal anemia and low birth weight is among the multiple
manifestations of Plasmodium falciparum malaria. Infected erythrocytes (iEs) can acquire various adhesive properties that
mediate the clinical severity of malaria. Recent advances on the molecular basis of virulence and immune evasion have
helped identify var2csa as a PAM-specific var gene.
Methodology/Principal Findings: The present study presents a genome-wide microarray transcript analysis of 18 P.
falciparum parasite isolates freshly collected from the placenta. The proportion of PAM over-expressed genes located in
subtelomeric regions as well as that of PAM over-expressed genes predicted to be exported were higher than expected
compared to the whole genome. The identification of novel parasite molecules with specificity to PAM and which are likely
involved in host-pathogen interactions and placental tropism is described. One of these proteins, PFI1785w, was further
characterized as the product of a two-exon PHIST gene, and was more often recognized by serum samples from P.
falciparum-exposed women than from men.
Conclusions/Significance: These findings suggest that other parasite proteins, such as PFI1785w, may contribute beside
VAR2CSA to the pathogenesis of PAM. These data may be very valuable for future vaccine development.
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Introduction
Clinical severity of Plasmodium falciparum malaria is linked in part
to alterations of the infected erythrocyte (iE) induced by parasite
proteins exported to the iE membrane during blood stage
development. Some of these proteins confer cytoadherence
properties to the iE, leading to parasite sequestration from the
blood stream. The best characterised parasite adhesin is P.
falciparum erythrocyte membrane protein 1 (PfEMP1), encoded by
the large polymorphic var gene family. This adhesin undergoes
antigenic variation, a phenomenon that is thought to contribute to
parasite evasion from the host immune response [1]. Certain
relatively conserved sub-families of PfEMP1 molecules have been
associated to differences in disease outcome [2,3,4].
Malaria during pregnancy and particularly first pregnancies is
associated with dramatic adverse effects on fetal growth (reviewed
in [5]). Primigravidae lack protective antibodies, which suggests
that pregnancy-associated malaria (PAM) parasites express novel
surface molecules to which women have not been exposed
previously [6,7,8,9]. PAM parasites show placental tropism and
specifically adhere to chondroitin sulphate A (CSA) [6,10]. Plasma
inhibitory activity to iE binding CSA is not dependent on the
geographical origin of parasites or plasma [7], indicating that
proteins mediating placental tropism are conserved between
parasite genotypes or contain shared epitopes and that a vaccine
against this form of malaria can be developed.
PfEMP1 proteins encoded by parasite var genes and expressed
on the surface of iEs were extensively shown to mediate various
binding activities hence representing an important target for
antibodies associated with protective immunity against malaria.
Several studies have shown that a single var gene, var2csa, is highly
transcribed and expressed in both in vitro CSA panned P. falciparum
iEs and parasites from infected placentas [4,11,12,13,14]. The
finding that antibody levels to VAR2CSA are dependent on sex
and gravidity and are associated with reduced consequences of
PAM [15,16] has further strengthened the candidacy of
VAR2CSA as the CSA adhesin in PAM. However, other genes
may be involved either in facilitating the VAR2CSA expression
PLoS ONE | www.plosone.org 1 March 2008 | Volume 3 | Issue 3 | e1855and binding or in other unknown PAM associated mechanisms.
Identification of these putative genes would be crucial for our
understanding of PAM and the development of a vaccine against
this particular form of malaria.
In the present study, DNA microarray analysis of genome-wide
expression profiles from 18 fresh P. falciparum isolates directly
collected from human placentas at delivery allowed the identifi-
cation of novel genes associated with placental tropism.
Results
Identification of differentially transcribed genes in
placental parasites compared to 3D7 reference
To assess the steady-state of mRNA levels of P. falciparum
infecting pregnant women, parasites were collected from the
placenta of delivering women in Senegal. Microscopic examina-
tion demonstrated a domination of late stage iEs (trophozoites and
shizonts) in all isolates. Due to the variable distribution of late
stages, samples were divided into 3 groups: (pool 1 included 3
isolates: #5% rings, 70% trophozoites, $25% schizonts; pool 2
with 7 isolates: #5% rings, $25% trophozoites, 70% schizonts;
pool 3 with 8 isolates: #5% rings, 0% trophozoites, $95%
schizonts). Total RNA was isolated from each individual sample
and RNA from individuals corresponding to each defined group
was pooled by mixing equal quantities of RNA. We chose to
explore placental parasite gene expression versus a common 3D7
reference and preferentially select the genes differentially
expressed in all 3 groups of placental parasites. Reference
parasite population was made-up of 10% rings, 45% trophozoites
and 45% schizonts. RNA pooled samples were fluorescently-
labeled prior to hybridization to an array of high-density
oligonucleotides.
Using the Bonferroni adjustment method, 84 genes consistently
displayed similar differential expression profiles in 2 out of 3
groups (over-expressed N=38; under-expressed N=46) (Figure 1,
Table 1). These genes generally had highly abundant transcripts
either in the test samples or in the 3D7 reference pool as judged by
spot fluorescence values. Var2csa was the only var gene unambig-
uously over-expressed. Over-expression in placental parasites was
observed in 14 out of 18 different var2csa oligonucleotides (data not
shown). Other var hybridising probes showing transcript abun-
dance differentials represented either truncated or pseudo-genes or
var exon2, [17].
The proportion of genes in subtelomeric regions over-expressed
by placental parasites was higher than expected compared to the
whole genome (p=3.2e-6) (figure 2, panel A); no such bias was
observed with placental parasites under-expressed genes. Similar-
ly, the proportion of over-expressed genes predicted to be exported
[18]was higher than expected compared to the whole genome
(p=4.5e-8) (figure 2, panel B), whereas no bias was observed with
placental parasites under-expressed genes.
Validation of microarray data by real-time PCR
To confirm the accuracy of the microarray results, the transcript
abundance of 13 selected genes was carried out. The genes were
selected based on over or under-expression, abundance of
transcripts and the presence of at least one TM, export prediction,
and/or signal sequence motifs (see supplement table S1). Real-
time PCR was performed first with the three pooled RNA/cDNA
samples used in the microarray analysis, then on RNA/cDNA
from each individual parasite sample included in the pool. Overall,
real-time PCR confirmed the arrays (Spearman correlation test
after log-transformation of the data, r=0.79, p,.0001) (Table 2).
Figure 1. Transcriptional characteristics of placental isolates.
Plots of log2 ratio of expression (M) against average log intensity (A) for
three different pools of placental isolates (pool 1 included 3 isolates:
#5% rings, 70% trophozoites, $25% schizonts; pool 2 with 7 isolates:
#5% rings, $25% trophozoites, 70% schizonts; pool 3 with 8 isolates:
#5% rings, 0% trophozoites, $95% schizonts) versus common 3D7
reference (10% rings, 45% trophozoites, 45% schizonts). Only statisti-
cally significant data according to Bonferroni p value correction are
shown. A single dominant var gene (var2csa) is detected in placental
isolates of all groups examined (red dots; each dot represents one
oligonucleotide). Non var genes over-expressed or under-expressed are
shown as black (when the difference was present in all 3 pools), green
(in 2 of the 3 pools). Blue dots correspond to oligonucleotides
corresponding to genes only differentially expressed in 1 out of 3
experiments (these were not taken into account in our analysis).
doi:10.1371/journal.pone.0001855.g001
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To further assess biological relevance of the microarray findings,
the transcription abundance of 13 genes selected for real-time
PCR was determined in parasites associated with different malaria
clinical backgrounds. Transcription abundance of the 13 genes
was also measured in laboratory-adapted parasite lines selected or
not for PAM phenotypes. By examining the transcription profiles
of parasites from different clinical groups, four categories of
transcription profiles were defined: (A): highest expression in
placental parasites (B): highest expression in parasites from
symptomatic women and asymptomatic children (C): highest
expression in parasites from symptomatic women and pregnant
women but not from asymptomatic children (Figure 3) and no
expression difference among parasites from all 3 clinical groups
(not shown). Overall 9 of the 13 tested genes behaved as
predicted regarding differential expression between parasites from
PAM and non-PAM donors. In group A, in addition to var2csa,
one gene, PFI785w, encoding a hypothetical protein displayed a
placental parasite-specific profile similar to that of var2csa.
PFI1785w encodes a 39.4 kD protein that is predicted to be
exported to the red blood cell (table S2). In group B (Figure 3),
the two RT-PCR tested genes found to be PAM under-expressed
by microarray analysis, PFD1120c and PF10_0350 were also
found under-expressed in placental parasites when compared to
non pregnant women and children parasites. In group C, the four
genes explored were over-expressed in symptomatic adults
compared to asymptomatic children.. Microarray detected PAM
over-expression of PF14_0757 was not confirmed by real-time
qPCR. However, although microarray data were confirmed by
RT-PCR for PF14_001, PFL0260c, no differential expression was
observed among the different groups of clinical isolates analyzed.
When transcript abundance of the 13 genes was measured in
laboratory-adapted parasite lines selected or not for CSA binding
phenotype (Figure 3, left panel), only var2csa, displayed a
marked specificity for CSA–binding [13,19].
Characterization of PFI1785w
The specific over-expression of PFI1785w by fresh placental
isolates, and not by non-PAM parasites or by in vitro CSA-selected
laboratory lines, raised a particular interest for further character-
ization. An interesting aspect of PFI1785w is the presence of a
PHIST (Plasmodium helical interspersed subtelomeric family)
domain, and thereby a predicted role in erythrocytic trafficking
or remodeling [18]. PFI1785w conforms to the canonical gene
structure of Pexel-containing proteins in which the signal peptide
is encoded by the first exon, and the Pexel motif and the
remainder of the protein are encoded on the second exon.
However, PFI1785w differs from almost all Pexel-encoding genes
in that it possesses a third exon according to the 3D7 annotation in
the current parasite database. The PFI1785w genomic sequences
amplified in this study confirmed the presence of the in-frame stop
codon at aminoacid position 146 in the 3D7 gDNA, which is not
present in the alleles from the Ghanaian (Sanger Institute Browser)
or HB3 (Broad Institute Browser) strains. However the spliced
structure as determined by PCR and sequencing of the cloned
3D7 PFI1785w gDNA and corresponding full size cDNA from
3D7 and from 2 placental isolates revealed existence of only one
Table 1. Total number of genes that were differentially
expressed in in vivo parasite isolates compared with
expression in in vitro 3D7 reference.
2 of 3 3 of 3 total
up down Up down up down
Oligos 28 30 27 17 55 47
Genes 19 30 19 16 38 46
Hypothetical protein 61 9 7 8 1 3 2 7
The number of oligos used and the number of those genes encoding
hypothetical or predicted exported proteins are also shown.
doi:10.1371/journal.pone.0001855.t001
Figure 2. Association plot between gene expression and, (A)
chromosome location, (B) predicted host cell export. Bar width
indicates the number of genes within each category while bar high
indicates deviations from an independent model showing categories
contributing to the disequilibrium. Result of chi2 test is indicated above
the legend. *Multi-copy gene families such as var, rif, stevor and Pfmc-
2TM were excluded from the data used to calculate the bias.
doi:10.1371/journal.pone.0001855.g002
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nucleotide position 189 and 358 (figure 4). All cDNA sequences
data have been submitted to the GenBank with the following
accession numbers: EU181220 (for 3D7), EU181221(for placental
isolate NTN42), EU181222 (for placental isolate NTN14). The
nucleotide sequence was highly conserved between 3D7 and the
two placental isolates cDNA. Only two point mutations were
observed. Our data indicate that the PFI1785w mRNA was
predicted incorrectly. This raises the necessity to confirm the
current annotation of the parasite genome with experimental data.
Part of the corresponding protein encoded by PFI1785w was
expressed in baculovirus transfected insect cells and purified as a
secreted HIS protein (that we called NP561). NP561 was
recognized in ELISA by serum samples from individuals living
in endemic areas (Ghana). Sera from women had significantly
higher levels of antibodies against NP561 compared to sera from
men of the same area in Ghana (p=0.04). Recognition of another
parasite recombinant protein (GLURP) was also measured and no
significant difference was observed between sera from both
genders (Figure 5).
Discussion
Many studies have generated convincing evidence of the unique
antigenic and binding properties of P. falciparum iEs collected from
the placenta. Previous analysis of the parasite variant surface
antigens has pointed to PfEMP1 variants as the major target of
antigenic variation and mediator of iE adhesion properties. Our
prior studies have shown that VAR2CSA PfEMP1 accounts for
CSA binding by iEs originating from the placenta [4]. The present
study has identified differences in gene expression compared to in
vitro 3D7 parasite reference, using the whole-genome microarray
analysis of P. falciparum parasites directly collected from the
placenta. First, this analysis confirmed var2csa (represented by 16
oligonucleotides) as the only var gene clearly over-expressed in all
placental parasite isolates. This however does not exclude possible
over-expression of other var genes, which were not represented on
the microarray due to sequence diversity. Second, along side with
the var2csa, a significant number of genes were over-expressed by
placental parasites, including genes predicted to encode exported
proteins and thus possibly contributing to parasite placental
tropism. For this whole-genome analysis of in vivo transcription of
placental parasites, stringent selection criteria were used i.e.
differential expression in at least 2 out of 3 pooled samples after
stringent Bonferroni p value adjustment. A common reference
containing all parasite erythrocytic stages with an emphasis on
schizonts and trophozoites, forms predominantly found in
placental isolates, was used. Although there are clearly defined
morphologic differences between the schizont, merozoite, and ring
stages, biological processes may be shared in contiguous stages.
Using a common reference was preferred to three separate
controls attempting to match the composition of each pool, as such
matching on morphological criteria is very difficult on late stages,
if not impossible. This allowed identification of 38 and 46 genes
over- or under-expressed in placental parasites respectively.
Of special interest is gene PFI1785w that was highly and
specifically over-expressed in placental parasites. The transcription
of PFI1785w displayed a clearly defined profile, similar to that of
var2csa, suggesting a specific association with placental parasites.
However, no evidence of its relation to the CSA binding
phenotype was seen in parasite lines biologically selected for in
vitro CSA binding. Several other genes were also over-expressed in
placental parasites, but not in in vitro selected CSA binding
parasites. This suggests either that these genes are selectively over-
expressed during pregnancy but are not directly involved in CSA
binding, or that conditions required for in vivo binding to
proteoglycans expressed by the placenta and in vitro binding to
CSA differ. A recent microarray study on individual parasites by
Francis et al. [20] also observed high transcription of PFI1785w by
placental parasites, and the expression of this particular PHIST
gene at the protein level was described by Fried et al. [21] in
membrane extracts from placental parasites. Although CSA
binding property represents the major specific phenotype of
placental parasites that can be reproduced in laboratory-adapted
parasite lines in vitro, some characteristics of parasites causing PAM
might require in vivo conditions for expression. We hypothesise that
this could be the case for PFI1785w expression.
The presence of a stop codon (...KKP-stop-KKPHP...) within
the 3D7 PFI1785w explains why the gene was miss-annotated as
an atypical three–exon PHIST gene and suggests that the
sequence downstream the stop codon is not necessary for 3D7
survival in vitro. However in other strains such as those causing
PAM the entire protein structure may be needed for placental
tropism of the parasite.
The recombinant protein (NP561) corresponding to part of the
protein encoded by this gene was more highly recognized by
serum samples from women living in malaria-endemic areas as
compared to serum from men. The relation to gender was less
strong than that of VAR2CSA, raising the question of this gene’s
exact role in the mechanisms governing P. falciparum placental
tropism. However, the importance of this relation was similar to
the one observed with recombinant PFD1140w in the Francis et
al. study [20], and the presence of significant levels of antibodies to
VAR2CSA has been reported among some men and children
[22]. Whether antibodies to PFI1785w express functional activity
Table 2. Confirmation by real-time quantitative rt-PCR of in
vivo expression of mRNA for 13 different genes, compared
with that in 3D7 in vitro reference.
Microarray fold change Gene ID rt-qPCR fold change
Group 1 Group 2 Group 3 Group 1 Group 2 Group 3
25,03 90,27 18,48 PFL0030c (+) 40,78 99,76 109,67
40,97 21,55 19,88 PFC0110w (+) 10,66 18,4 23,15
7,08 35,45 4,63 PFI1785w (+) 149,15 319,69 206,25
5,5 12,89 3,43 PF10_0351 (+) 5,56 6,63 5,03
5,61 12,74 3,1 PFA0700c (+) 103,7 171,37 112,99
5,61 3,74 3,54 PF14_0010 (+) 10,2 26,48 5,75
8,36 3,39 2,69 PF10_0344 (+) 2,76 3,81 1,91
3,31 2,93 4,59 PF14_0757 (+) 2,84 1,63 0,81
6,72 2,55 PFB0105c (+) 3,95 4,4 4
PF13_0304 (=) 0,94 1,2 0,72
0,34 0,23 PFL0260c (2) 0,16 0,22 0,28
0,32 0,17 PF10_0350 (2) 0,56 0,61 0,26
0,3 0,3 0,16 P FD1120c (2) 0,26 0,22 0,19
Gene’s selection criteria were based on similar expression observed in at least 2
out 3 tests sample pools. Values are fold changes calculated as compared to the
3D7 level. Gene expression levels ranged from overexpressed in in vivo parasites
to fairly expressed according to arrays measurements. (+) For over-expressed in
placental parasites according to array data and (2) For under-expressed in
placental parasites according to array data. One gene with no difference in
expression (=) according to microarray was also included. Empty cells
correspond to no difference observed.
doi:10.1371/journal.pone.0001855.t002
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Differential acquisition of these antibodies between men and
pregnant women should also be confirmed in a dedicated
seroepidemiological survey.
PFI1785w is a single copy gene that encodes a small protein
likely exported to the red blood cell as judged by its predicted
signal sequence and export motif. The gene is found conserved
(.98%) at the nucleotide level in all 4 species of Plasmodium spp
Figure 3. Transcription levels measured by real-time qPCR in parasites from different clinical malaria status. Blocks A to C, left panels
correspond to higher transcription levels in: (A) placental parasites from pregnant women at delivery (PW); (B) non placental parasites from children
(C) and non placental parasites from non pregnant symptomatic women (NPW); (C) parasites from women (PW or NPW). Shown are transcription
levels for 22 parasites isolated from the placenta of women (PW), 9 parasites from asymptomatic children (C) (mean age 10 years) and 4 parasites
from symptomatic non-pregnant women (NPW) living in the same area, as well as by (in the right side of each panel) the in vitro cultured P.
falciparum strains 3D7 (black dots), FCR3 (red dots), and NF54 (blue dots). Each of these 3 strains were used either non-selected or after selection for
CSA binding using panning on soluble CSA (3D7), Bewo cells (FCR3), or VAR2CSA IgGs (NF54). Hb3 (yellow dots) was also studied after selection on
Bewo cells. These parasite lines were highly synchronized and aged 24 hours post invasion Missing points correspond to lack of detection of the
corresponding gene (in particular for PFI1785w in FCR3). Horizontal bars indicate statistically significant differences between groups. On top, (+)
indicates over-expressed in PAM parasites according to array data; (2) indicates under-expressed in PAM parasites according to array data.
doi:10.1371/journal.pone.0001855.g003
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suggesting that the product of this gene plays an important role for
the survival of Plasmodium, but argues against a direct role in
antigenic variation on the surface of the infected red blood cell. No
evidence has been presented that the PHIST proteins in general
are surface antigens, and none of them have TM domains. In
contrast to PfEMP1 and RIFIN proteins, they exhibit no amino
acid diversity between isolates; for example, comparison of
PFI1785w alleles between 3D7 and HB3 (Broad Institute browser),
the Ghanaian isolate (Sanger browser) or placental isolates from
our study shows essentially 100% sequence conservation.
A recent study identified a ,22 KDa protein as being involved
in the binding of iEs to CSA [23]. In the present study, high
transcription of a number of genes encoding low molecular weight
proteins with predictive characteristics for red blood cell trafficking
was specifically observed in placental isolates. Notable examples
include, along with PFI1785w (44 KDa corrected here),
PFA0700c (12.83 KDa), PF14_0757 (24.95 KDa), and PFB0105c
(35.3 KDa). In our study, PF14_0757 with its theoretical
molecular weight of 24.95 KDa is the closest in size to this
potential protein, but its transcription was not shown to
significantly differ between placental and non-placental parasites.
Among the 5 genes found by Francis et al. [20] to be specifically
co-transcribed with var2csa by placental parasites when analyzing
individual isolates, four were also identified in our study
(PFI1785w, PFL0050c, PFD1140w, PFB0115w). However only
PFI1785w met our own criteria of interesting genes (high
expression in at least 2 out of the 3 test pools). PFD1140w, the
main candidate gene characterized in the Francis et al. study [20]
was also detected here, but only in the pool with domination of
trophozoites. This apparent discrepancy suggests a stage-depen-
dent expression of the PFD1140w gene. Proteins from 2
(PFI1785w and PFA700c) genes with interesting scores in our
study were also detected by Fried et al [21]. For 3 other genes
(PFB0115w, PF14_0016, PF14_0260) for which proteins were
detected in the same study, differential expression was only
recorded in 1 of the 3 test pools. With PF14_0016 and PF14_0260
rather showing PAM under-expression in our study.
Our results suggest that many sub-telomeric genes in P.
falciparum genome play a role in host-parasite interactions. As
sub-telomeric genes, PHIST appears dissimilar to any known
structure, making it difficult to assign possible functions to
members of this family. A published microarray study of field
isolates has shown that most genes from PHISTb and PHISTc
families are over-expressed in P. falciparum parasites directly
collected from infected children compared to 3D7 [24]. As shown
in table S2, in the present study, 4 genes belonging to the three
PHIST families, i.e. PF14_0757, PFA110w, PFI1785w and
PFB105c were found over-expressed in PAM parasites compared
to 3D7. Thus, it is all the more interesting that proteomic data
Figure 4. PFI1785w spliced structure. (A) PCR products confirming splicing of intron 1 but not intron 2 on 3D7 and a placental isolate cDNA.
Primers indicated on (A) by arrows were used to amplify full size and a short fragment of the gene on 3D7 genomic DNA (lane 2 and 5), and on cDNA
of 3D7 (lane 3 and 6) and a placental isolate (lane 4 and 7). Lane 1 indicates a 100 bp DNA lader. (B) Diagram of exon/intron structures from predicted
gene and mRNA/cDNA. The heavy bars are predicted exons. Empty and stripped bars are predicted intron 1 and intron 2 respectively according to
3D7 gDNA sequence. Figures below the gDNA structure indicate nucleotide positions. mRNA/cDNA structure is the experimentally observed
structure.
doi:10.1371/journal.pone.0001855.g004
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in iE membrane preparations [21,25,26,27].
These findings suggest that other parasite proteins beside
VAR2CSA may contribute to the pathogenesis of PAM.
Prospective clinical studies are needed to estimate the importance
of those new proteins in the mechanism controlling acquisition of
distinct binding and serological phenotypes by P. falciparum and
thus, identification of critical targets for intervention.
Materials and Methods
Patients, sample collection and storage
Samples were collected in November 2003 in Guediawaye, a
suburb of Dakar, Senegal. The human experimentation guidelines
of both French and Senegalese governments were followed.
Women were explained the nature of the project, and informed
verbal consent was obtained in the presence of an external and
independent witness. The study design, the sampling protocol, as
well as the way to collect informed consent were approved by the
ethical committee of the Ministry of Health, Senegal. Notably
verbal consent was considered valid and recommended in this
context of poorly literate study population. Pregnant women,
admitted for delivery, were enrolled when blood smears and/or
immuno-chromatography test were positive for P. falciparum
infection. Non-pregnant women who presented with fever and
whose blood smears were positive for P. falciparum infection, were
also enrolled as controls. Clinical data were registered and 10 ml
of peripheral blood were collected in sodium heparin. Peripheral
ring stages iEs were matured for 18–20 h at 37uC in a candle jar
[28]. Placental parasites were obtained by perfusing the placenta
with 0.1% sodium heparin in PBS [29]. Parasites were conserved
in Trizol (Invitrogen) and stored at 280uC, or as spots on
Whatman 3MM filter that were dried and stored at room
temperature, until subsequent RNA and DNA extractions. Plasma
was separated from the peripheral blood and stored at 220uC
until use.
During the same period, venous blood samples were collected
from asymptomatic infected children in a paralleled on-going
cross-sectional study conducted in the neighboring area of Thie `s
[30]. Samples were collected following the same protocols
described above.
Parasite culture and selection for specific phenotypes
P. falciparum strains were cultured as described [31]. The 3D7
strain was sorbitol-synchronized 4 times with an interval of
8 hours to obtain tightly synchronous stages. Strains FCR3 and
HB3 were previously panning-selected for adhesion to CD36 or
Bewo cells as described [32]. The NF54 strain was selected using
antibodies specific to the var2csa-encoded PfEMP1 as described
[33]. The 3D7 was also panning-selected for adhesion to
immobilized CSA. After selection, parasites were cultured 5–6
cycles to generate sufficient parasite density. Mature stages were
enriched by Macs purification, as described [34]. In vitro panning-
selected lines were characterized by reactivity with IgG from
multiparous women and lack of reactivity with IgG from P.
falciparum-exposed men [6,9,35].
DNA and total RNA extractions
Genomic DNA was extracted from filter spots using the chelex
procedure [36]. Total RNA from iE containing trophozoite/
schizont stage parasites from placental and matured peripheral
blood was prepared using organic extraction from Trizol. RNA
quality was assessed with Agilent 2100 Bioanalyser.
Microarrays
The microarrays used here are described elsewhere [12].
Briefly, glass slides were spotted with 8870 70-mer oligonucleotides
originating from the Malaria Oligo Set (Qiagen-Operon) and
custom design oligonucleotides, covering most of all P. falciparum
genes. Of the 5542 identified genes, the array covers 5396 genes
(97.4%) including protein coding, rRNA, tRNA, snRNA and
pseudogenes. Due to the variable distribution of late stages in
different isolates after placental perfusion (thin smears reads
against 200 parasites), RNA samples from 18 women were pooled
into 3 groups. The 3D7 reference was made-up of 10% rings, 45%
trophozoites and 45% schizonts. Integrity of the RNA transcripts
from each test sample was assessed with an Agilent 2100
Bioanalyser. RNA samples labelling and hybridization were
performed as described previously [12].
For each of the three pools of placental parasites, two dye swaps
were performed to compensate dye effect and to assess technical
reproducibility, leading to four hybridized slides. Data from each
of the three pools were analyzed separately using R function (The
R project) and Bioconductor package [37] as described previously
[12]. After normalization, a paired Student t test was used to assess
differentially expressed spots and the raw p values were then
corrected using the Bonferroni method with a type 1 error of 0.05.
Log2 ratios of pooled placental parasites versus 3D7 pooled
reference was obtained for genes which were found differentially
transcribed in at least 2 of 3 test pools and presented in S2. Our
data have been submitted to the publicly available ArrayExpress
database with the following accession number: E-MEXP-1087.
Figure 5. Recognition of PFI1785w recombinant protein
(NP561) by sera from malaria exposed individuals assessed
by ELISA. ELISA was carried out on NP561, DBL5-e of VAR2CSA and
GLURP coated plates. The levels of IgG expressed as OD values are
shown for exposed Ghanaian men (n=30; white bars) and women
(n=30; grey bars). The top, bottom, and line through the middle of the
box correspond to the 75
th percentile, 25
th percentile, and 50
th
percentile (median), respectively. The whiskers on the bottom extend
from the 10
th percentile and top 90
th percentile. Plasma concentrations
of anti-VAR2CSA and anti-NP561 IgG were significantly higher in the
women group.
doi:10.1371/journal.pone.0001855.g005
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Gene-specific real time PCR primers were made based on the
3D7 sequences for 13 selected genes (supplement Table S1).
Primer amplification efficiency was tested on serial dilutions of
gDNA from three laboratory isolates (3D7, FCR3, and HB3) and
three different field isolates. Melting curve analysis and agarose gel
electrophoresis ensured specificity. The var2csa specific primers
used are described previously [4].
For real-time PCR, RNA Trizol extraction was followed by
15 min DNase 1 (Sigma) treatment at 37uC. Absence of DNA
contamination was assessed by 40 cycles of real time PCR using
primers targeting a previously validated endogenous control gene
(fructose-biphosphate aldolase) [13]. DNA-free RNA was reverse
transcribed using random hexamer primers with Superscript II
enzyme (Invitrogen) at 25uC for 10 min, and 42uC for 50 min
followed by 70uC for 15 min.
Quantitative real time PCR was performed on cDNA using a
Rotorgene thermal cycler system (Corbett Research) [13].
Reactions were done in 20 ml volumes using Quantitect SYBR
Green PCR Master Mix (Qiagen) and 0.5 mM primers [13].
Quantitative analysis of the gene-expression level was done using
Rotorgene software version 4.6. Transcripts abundances were
compared by DCt values calculated using fructose-biphosphate
aldolase as endogenous control.
Differences between groups of samples studied by real-time rt-
PCR were tested by the appropriate non-parametric test (Mann-
Whitney two samples rank sum test). Correlations were tested by
the Spearman rank sum test. The significant limit was P=0.05.
STATA software (version 7.0, STATA Corporation) was used.
Sequencing and recombinant proteins generation
The PlasmoDB predicted protein encoded by PFI1785w in the
P. falciparum clone 3D7 genome, was selected for expression as a
soluble protein. The product of this gene is predicted to be
exported according to Sargeant et al. [18]. Primers were designed
to amplify and clone the full size cDNA and also gDNA, and a
fragment of 672 bp from the start codon in order to contain both
predicted introns in the 3D7 gene. The forward primer used in the
generation of the recombinant protein, NP561, was designed
downstream of the apparent stop codon, to avoid a potential un-
spliced stop. The sequence from 391 bp to 967 bp was amplified
from 3D7 gDNA using the following primers that included EcoR1
and Not1 restriction sites in 59 and 39 respectively. Fw:
CAATCAAGATATAATAGATCA; Rv: CGGTTTTACCCT-
TATAATG. All inserts were cloned into a modified pAcGP67A
vector containing EcoR1 and Not1 restriction sites, and
recombinant proteins produced in baculovirus-infected insect cells
and purified as described [15]. The purified recombinant protein
named NP561, corresponding to about 70% of the full size of the
protein was subsequently used as antigen in this study.
Enzyme-linked Immunosorbent Assay
Plasma levels of P. falciparum-specific IgG were measured in
ELISA using recombinant VAR2CSA (DBL5e) or NP561 protein
for coating. GLURP recombinant protein was used as control
antigen. Two panels of plasma samples from P. falciparum thick
blood smear negative Ghanaian individuals (30 women of various
gravidity and 30 sympatric males) exposed to hyperendemic and
seasonal malaria transmission were used [15]. Sera from the two
groups were previously characterized for their sex-specific and
parity-dependent recognition of VAR2CSA DBL5e and CSA-
adherent parasites [15]. A pool of plasma samples from unexposed
Danish women was used as a negative control. Antibody levels
were analyzed and expressed as OD values.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0001855.s001 (0.05 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0001855.s002 (0.35 MB
DOC)
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